Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Axe Compute Inc stock logo
AGPU
Axe Compute
$8.26
-4.0%
$10.66
$1.03
▼
$13.49
$96.53M3.661.31 million shs147,123 shs
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$9.66
-10.1%
$10.67
$0.71
▼
$16.54
$32.79M1.35473,545 shs437,782 shs
Tucows Inc. stock logo
TCX
Tucows
$9.69
+1.0%
$10.42
$8.45
▼
$25.17
$108.65M0.9248,922 shs1,630 shs
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
$0.78
-14.1%
$4.49
$0.78
▼
$7.39
$26.28MN/A285,961 shs6.58 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Axe Compute Inc stock logo
AGPU
Axe Compute
-10.97%-28.57%-20.07%+27.22%+859,999,900.00%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-10.14%-21.40%-13.52%+39.19%-28.87%
Tucows Inc. stock logo
TCX
Tucows
+0.52%0.00%-8.32%-3.52%-47.74%
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
-1.83%-10.93%-83.24%-91.82%-91.14%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Axe Compute Inc stock logo
AGPU
Axe Compute
$8.26
-4.0%
$10.66
$1.03
▼
$13.49
$96.53M3.661.31 million shs147,123 shs
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$9.66
-10.1%
$10.67
$0.71
▼
$16.54
$32.79M1.35473,545 shs437,782 shs
Tucows Inc. stock logo
TCX
Tucows
$9.69
+1.0%
$10.42
$8.45
▼
$25.17
$108.65M0.9248,922 shs1,630 shs
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
$0.78
-14.1%
$4.49
$0.78
▼
$7.39
$26.28MN/A285,961 shs6.58 million shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Axe Compute Inc stock logo
AGPU
Axe Compute
-10.97%-28.57%-20.07%+27.22%+859,999,900.00%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-10.14%-21.40%-13.52%+39.19%-28.87%
Tucows Inc. stock logo
TCX
Tucows
+0.52%0.00%-8.32%-3.52%-47.74%
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
-1.83%-10.93%-83.24%-91.82%-91.14%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Axe Compute Inc stock logo
AGPU
Axe Compute
2.50
Moderate BuyN/AN/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
0.00
N/AN/AN/A
Tucows Inc. stock logo
TCX
Tucows
1.00
SellN/AN/A
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest XLAB, TCX, AGPU, and POAI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/9/2026
Tucows Inc. stock logo
TCX
Tucows
DowngradeSell (D-) ➝ Sell (E+)
9/26/2026
Axe Compute Inc stock logo
AGPU
Axe Compute
UpgradeStrong-Buy
9/22/2026
Tucows Inc. stock logo
TCX
Tucows
UpgradeSell (E+) ➝ Sell (D-)
9/4/2026
Tucows Inc. stock logo
TCX
Tucows
DowngradeSell (D-) ➝ Sell (E+)
8/27/2026
Axe Compute Inc stock logo
AGPU
Axe Compute
Reiterated RatingSell (D-)
8/14/2026
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
UpgradeSell (E) ➝ Sell (D-)
8/5/2026
Tucows Inc. stock logo
TCX
Tucows
UpgradeSell (E+) ➝ Sell (D-)
7/28/2026
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
DowngradeSell (E+) ➝ Sell (E)
7/21/2026
Tucows Inc. stock logo
TCX
Tucows
DowngradeSell (D-) ➝ Sell (E+)
(Data available from 10/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Axe Compute Inc stock logo
AGPU
Axe Compute
$3.26M29.34N/AN/A$11.69 per share0.71
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$1.66M19.70N/AN/A($0.46) per share-21.00
Tucows Inc. stock logo
TCX
Tucows
$390.30M0.28N/AN/A($14.78) per share-0.66
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Axe Compute Inc stock logo
AGPU
Axe Compute
-$233.10M-$5.75N/AN/AN/A-7,769.61%-1,606.56%-355.39%N/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-$12.66M-$13.50N/AN/AN/A-5,065.23%-732.73%-235.55%N/A
Tucows Inc. stock logo
TCX
Tucows
-$75.82M-$7.53N/AN/AN/A-21.20%N/A-9.48%11/5/2026 (Estimated)
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest XLAB, TCX, AGPU, and POAI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Axe Compute Inc stock logo
AGPU
Axe Compute
N/A-$0.87N/A-$0.87N/A$3.21 million
8/14/2026Q2 2026
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
N/A$0.05N/A$0.05N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Axe Compute Inc stock logo
AGPU
Axe Compute
N/AN/AN/AN/AN/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/AN/A
Tucows Inc. stock logo
TCX
Tucows
N/AN/AN/AN/AN/A
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Axe Compute Inc stock logo
AGPU
Axe Compute
N/A
1.45
1.45
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/A
0.01
0.01
Tucows Inc. stock logo
TCX
Tucows
N/A
0.57
0.57
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Axe Compute Inc stock logo
AGPU
Axe Compute
9.04%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
9.04%
Tucows Inc. stock logo
TCX
Tucows
73.64%
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
N/A

Insider Ownership

CompanyInsider Ownership
Axe Compute Inc stock logo
AGPU
Axe Compute
1.21%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
1.21%
Tucows Inc. stock logo
TCX
Tucows
8.40%
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Axe Compute Inc stock logo
AGPU
Axe Compute
1411.59 million11.45 millionN/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
303.39 million3.35 millionNot Optionable
Tucows Inc. stock logo
TCX
Tucows
75911.18 million10.24 millionOptionable
D. Boral ARC Acquisition I Corp. stock logo
XLAB
D. Boral ARC Acquisition I
233.69 millionN/AN/A

Recent News About These Companies

D. Boral ARC Acquisition I (NASDAQ:XLAB) Shares Down 1.8% - What's Next?
ARCLR - ARC Group Acquisition I Corp RT EXP 042131
D. Boral Acquisition I Corp. Cl A
D. Boral Arc Acquisition I Corp. Class A
DBCA D. Boral Acquisition I Corp.
DBCAU D. Boral Acquisition I Corp. Units
D. Boral ARC Acquisition I Corp.
D. Boral ARC Acquisition I Corp. Cl A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Axe Compute stock logo

Axe Compute NASDAQ:AGPU

$8.26 -0.34 (-3.97%)
As of 10:15 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

Predictive Oncology stock logo

Predictive Oncology NASDAQ:POAI

$9.66 -1.09 (-10.14%)
As of 10/13/2026

Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.

Tucows stock logo

Tucows NASDAQ:TCX

$9.68 +0.10 (+0.99%)
As of 10:13 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Tucows Inc. provides network access, domain name registration, email, mobile telephony, and other Internet services in North America and Europe. It operates in three segments: Ting, Wavelo and Tucows Domains. The Ting segment provides fiber and fixed wireless internet services. The Wavelo segment offers individual developer tools, subscription, billing management, network orchestration, and provisioning services. This segment also provides billing solutions under Platypus brand. The Tucows Domains segment offers name registration, as well as value added services under OpenSRS, eNom, Ascio, EPAG, and Hover brands. The company was formerly known as Infonautics, Inc. and changed its name to Tucows Inc. in August 2001. Tucows Inc. was incorporated in 1992 and is headquartered in Toronto, Canada.

D. Boral ARC Acquisition I stock logo

D. Boral ARC Acquisition I NASDAQ:XLAB

$0.78 -0.13 (-14.13%)
As of 09:58 AM Eastern

We are a blank check company incorporated on March 20, 2025 as a BVI business company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business. We will seek to acquire one or more businesses with an aggregate enterprise value of $700 million or greater, although, if we believe it is in the best interests of our shareholders, we may pursue a business combination with a target below that size. We believe that the experience and capabilities of our management team will make us an attractive partner to potential target businesses, enhance our ability to complete a successful business combination, and bring value to the business post-business combination. Not only does our management team bring a combination of operating, investing, financial and transactional experience, but members of our management team have also worked closely together in the past at multiple operating companies and have successfully identified and closed two special purpose acquisition company (“SPAC”) business combinations. Our team has broad sector knowledge though their collective involvement across a variety of industries, as well as extensive global capital markets experience, with local and cross-border capabilities allowing access to different sectors of the capital markets. Our management team is led by David Boral, our Chairman and Chief Executive Officer, and John Darwin, our Chief Financial Officer and a member of our board of directors. David Boral has served as our Chairman and Chief Executive Officer since March 2025. Mr. Boral is also the chief executive officer and founder of D. Boral Capital, a global investment bank which he established in May 2020. In his role as chief executive officer, Mr. Boral ensures that the company’s vision and strategy are executed daily through the efforts of the D. Boral Capital team. Before founding D. Boral Capital, Mr. Boral held several leadership roles in Investment Banking and Capital Markets. With approximately 20 years of experience, Mr. Boral has led and participated in a wide range of transactions, including traditional IPOs, SPAC IPOs & de-SPAC transactions, follow on and secondary offerings, private placement/PIPEs, reverse mergers, bankruptcies and restructurings, dual and cross-listings, and other private and public offerings both in the U.S. and internationally. Mr. Boral served as Co-President and a Director of EF Hutton Acquisition Corporation I, a special purpose acquisition company from March 3, 2021 until it completed its initial business combination on December 12, 2023. Mr. Boral received a BBA in Finance from the Lubin School of Business at Pace University. John Darwin has served as our Chief Financial Officer and a member of our board of directors since March 2025. Since 2022, Mr. Darwin has served as a managing director at ARC Group Limited, a global investment bank and management consultancy firm. Mr. Darwin has deep experience as a SPAC executive, board member, and private equity investor in emerging industries across a wide range of geographies. Before joining ARC Group, Mr. Darwin was Managing Partner of Luminous Capital USA, Inc., a U.S. based private investment firm focused on emerging industries and technologies since December 2020. While at Luminous USA, Inc., Mr. Darwin was Co-Chief Executive Officer and a Director of Northern Lights Acquisition Corp., a special purpose acquisition company, from June 2021 until it completed its initial business combination in September 2022. Previously, from March 2018 to March 2021, Mr. Darwin was President of OCG, Inc., a U.S. based retail franchisor. Prior to OCG, Mr. Darwin held various roles in private equity and corporate finance and has over a decade of transaction experience in public and private entities. Mr. Darwin received his BBA in Finance from the Cox School of Business at Southern Methodist University. Our executive offices are located in New York, NY.